Get the Stockscreener App
34.77
4.98%
-1.705
Direxion Daily Tsm Bull 2 X Shares stock is traded at $34.77, with a volume of 433.37K.
It is down -4.98% in the last 24 hours and up +8.60% over the past month.
See More
Previous Close:
$36.47
Open:
$34.55
24h Volume:
433.37K
Relative Volume:
0.81
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.93%
1M Performance:
+8.60%
6M Performance:
+9.39%
1Y Performance:
+0.00%
1-Day Range:
$33.43
$34.88
1-Week Range:
$33.43
$38.04
52-Week Range:
$12.15
$38.64
Direxion Daily Tsm Bull 2 X Shares Stock (TSMX) Company Profile
Name
Direxion Daily Tsm Bull 2 X Shares
Sector
Industry
Phone
-
Address
-
Compare TSMX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TSMX
Direxion Daily Tsm Bull 2 X Shares
|
34.77 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
306.76 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
623.82 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
626.82 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
237.68 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
556.90 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Tsm Bull 2 X Shares Stock (TSMX) Latest News
TSM Earnings in Focus: How Traders Can Double Down or Hedge with Leveraged ETFs Before July 17 - Barchart.com
Leveraged ETFs in a Bullish Market: Tactical Gains and the Perils of Compounding Volatility - AInvest
Investors May Keep Dipping Into Chips Following Bill Passage - ETF Database
European Defense Boom & The Rise Of Leveraged Single-Stock ETFs - Barchart.com
France's prime minister wants to cut 2 public holidays to save money for the indebted economy - Barchart.com
Market Makers May Be Favorably Mispricing MARA Holdings Options: Here’s How We Know - Barchart.com
Cotton Holding Higher On Tuesday - Barchart.com
Audited and Early-Stage: Why Ruvi AI (RUVI) Is Becoming the Go-To Pick Over Tron (TRX) for Over 104x Returns - Barchart.com
Top Mobile Payments Stocks To Buy To Ride The Cashless Wave - Barchart.com
How About Those Crop Condition Numbers For Corn And Soybeans? - Barchart.com
Glioblastoma Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Treatment, Therapies and Companies by DelveInsight - Barchart.com
Smart Investors Are Rushing Into Ruvi AI (RUVI), The $0.015 Audited Token Tipped to Be the Next Binance Coin (BNB) - Barchart.com
Best Under $1 Token? Smart Investors on Ruvi AI’s (RUVI) Audited Token Over Shiba Inu (SHIB) for 13,800% ROI - Barchart.com
Chinese Economy Grows At A 5.2% Annual Pace In April-June Quarter Despite Trade War - Barchart.com
China reports its economy slowed in the last quarter, but still grew at a robust 5.2% annual pace - Barchart.com
Sesame Workshop Regains Control Of Elmo's Hacked X Account After Racist Posts - Barchart.com
Soybeans Weakness Continues On Monday - Barchart.com
Global Artificial Intelligence in Oncology Market Size to Hit USD 2,145.1 Million by 2025, grow at a CAGR of 33.7% | Coherent Market Insights - Barchart.com
3 Things This Top Analyst Says Can Save Tesla Stock Now - Barchart.com
AngloGold Ashanti Skyrockets 104% YTD: How To Play The Stock? - Barchart.com
Alibaba Stock Is Well Off Its HighsWhat Is The Best Way To Play BABA? - Barchart.com
Soybeans Slipping Into Midday - Barchart.com
Goldman's Q2 Earnings On The Deck: Here's How To Play The Stock Now - Barchart.com
Mission Produce Rides On Price Volatility: Can It Sustain Growth? - Barchart.com
Zacks Industry Outlook Highlights Groupon And CarGurus - Barchart.com
Zacks Market Edge Highlights: NVIDIA, Amazon.com And Microsoft - Barchart.com
Zacks Investment Ideas feature highlights: Fastenal, Taiwan Semiconductor Manufacturing and Netflix - Barchart.com
Zacks Industry Outlook Highlights Apple And Dell Technologies - Barchart.com
Bulls Battle Back After New Tariff Threats - Barchart.com
CELH Stock Trades At Premium Value: Should You Buy, Hold Or Sell? - Barchart.com
ASML Likely To Beat Q2 Earnings Estimates: How To Play The Stock? - Barchart.com
Capitalize On Bitcoin's Bull Run With Leveraged ETFs In Crypto Week - Barchart.com
Best-Performing Leveraged ETFs Of Last Week - Barchart.com
AgencyUP Annual Mini-Accelerator Provides C-Level Marketing To Small Businesses - Barchart.com
MP Materials Hits 52-Week High: Should You Buy, Hold Or Sell? - Barchart.com
Bet On E-Commerce Growth With Groupon And CarGurus - Barchart.com
SMCI Vs. VRT: Which Stock Has An Edge In The Liquid Cooling Space? - Barchart.com
ABBV Or BMY: Which Biopharma Giant Has Better Prospects For Now? - Barchart.com
EWCZ Marketing Shift Shows Early Wins: Can Growth Reignite Fast? - Barchart.com
Circle Stock Warning: CRCL Could Fall More Than 50% From Here - Barchart.com
HIVE Digital Technologies Exceeds 12 EH/s Milestone, Achieves $250 Million Annual Run Rate Revenue as Paraguay Expansion Progresses - Barchart.com
Tower Hits High-Grade 23.63 g/t Gold over 6.02 m Near Surface in Hole 060 at Blue Sky, 70 m NE of Hole 055, Underscoring the Potential of the Durand Diorite to Host a Substantial Gold Deposit - Barchart.com
Experts Tip Ruvi AI (RUVI) as a Giant in the Making, Utility Focused and Successful Audit Spark 13,800% ROI Forecast - Barchart.com
Will Celsius' Innovation Strategy Fuel Its Next Wave Of Growth? - Barchart.com
Lululemon Bets On Footwear & Men's Category: Will It Pay Off? - Barchart.com
Valkea Resources Plans Aggressive Exploration Programs Across Its Northern Finland Project Portfolio - Barchart.com
ZTE's "Signal Reach Program" Wins WSIS 2025 Champion Award - Barchart.com
Diabetic Retinopathy Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | | Kodiak Sciences, Novartis, Regenxbio Inc., OcuTerra Therapeutics - Barchart.com
JPMorgan Q2 Earnings On The Deck: A Smart Buy Or Risky Bet? - Barchart.com
3 ETFs To Buy Now To Profit From The AI Boom - Barchart.com
AMD And Nvidia Stock Investors Just Got Amazing News From 2 Wall Street Analysts - Barchart.com
Direxion Daily Tsm Bull 2 X Shares Stock (TSMX) Financials Data
There is no financial data for Direxion Daily Tsm Bull 2 X Shares (TSMX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.92%
Cap:
|
Volume (24h):